Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle

Journal of Neuroimmunology

Volumn 189, Issue 1-2, 2007, Pages 158-162

  Kuwabara, Satoshi ^a   Misawa, Sonoko ^a   Takahashi, Hirokatsu ^a   Sawai, Setsu ^a   Kanai, Kazuaki ^a   Nakata, Miho ^a   Mori, Masahiro ^a   Hattori, Takamichi ^a   Yuki, Nobuhiro ^b  

^a CHIBA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

anti GQ1b antibody; Miller Fisher syndrome; Motor nerve terminal; Neuromuscular transmission; Single fiber electromyography

Indexed keywords

GANGLIOSIDE GQ 1B ANTIBODY; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROMYOGRAPHY; FEMALE; FOREARM; GUILLAIN BARRE SYNDROME; HUMAN; LIMB; MALE; NERVE ENDING; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; FEMALE; GANGLIOSIDES; HUMANS; MALE; MILLER FISHER SYNDROME; MUSCLE FIBERS; NEUROMUSCULAR JUNCTION; RETROSPECTIVE STUDIES; REVIEW LITERATURE AS TOPIC; SYNAPTIC TRANSMISSION;

EID: 34548501773     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.07.001     Document Type: Article

References (32)

1. Buchwald B., Weishaupt A., Toyka K.V., and Dudel J. Immunoglobulin G from a patient with Miller-Fisher [sic] syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci. Lett. 201 (1995) 163-166
2. Buchwald B., Weishaupt A., Toyka K.V., and Dudel J. Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher [sic] syndrome IgG at mouse motor nerve terminals. Eur. J. Neurosci. 10 (1998) 281-290
3. Buchwald B., Toyka K.V., Zielasek J., Weishaupt A., Schweiger S., and Dudel J. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study. Ann. Neurol. 44 (1998) 913-922
4. Buchwald B., Bufler J., Carpo M., Heidenreich F., Pitz R., Dudel J., Nobile-Orazio E., and Toyka K.V. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome. Neurology 56 (2001) 67-74
5. Buchwald B., Ahangari R., and Toyka K.V. Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction. Neurosci. Lett. 334 (2002) 25-28
6. Bullens R.W., Halstead S.K., O'Hanlon G.M., Veitch J., Molenaar P.C., Willison H.J., and Plomp J.J. Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse. Muscle Nerve 31 (2005) 751-760
7. Chiba A., Kusunoki S., Shimizu T., and Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31 (1992) 677-679
8. Chiba A., Kusunoki S., Obata H., Machinami R., and Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43 (1993) 1911-1917
9. Halstead S.K., Morrison I., O'Hanlon G.M., Humphreys P.D., Goodfellow J.A., Plomp J.J., and Willison H.J. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia 52 (2005) 177-189
10. Jacobs B.C., Bullens R.W., O'Hanlon G.M., Ang C.W., Willison H.J., and Plomp J.J. Detection and prevalence of α-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome. Muscle Nerve 25 (2002) 549-558
11. Jacobs B.C., O'Hanlon G.M., Bullens R.W., Veitch J., Plomp J.J., and Willison H.J. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 126 (2003) 2220-2234
12. Kaida K., Kusunoki S., Kanzaki M., Kamakura K., Motoyoshi K., and Kanazawa I. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome. Neurology 62 (2004) 821-824
13. Kishi M., Fujioka T., Miura H., Sekine A., Iguchi H., Nakazora H., Kiyozuka T., Igarashi O., Ichikawa Y., Sugimoto H., Kurihara T., Irie S., and Saito T. The relation of clinical symptoms and anti-ganglioside antibodies to MEPPs frequency increase in 8 cases of variant type Guillain-Barre syndrome. J. Peripher. Nerv. Syst. 8 (2003) 82-90
14. Kuwabara S., Nemoto Y., Misawa S., Takahashi H., Kawaguchi N., and Hattori T. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles. Acta Neurol. Scand. 115 (2007) 126-128
15. Lange D.J., De Angelis T., and Sivak M.A. Single-fiber electromyography shows terminal axon dysfunction in Miller Fisher syndrome: a case report. Muscle Nerve 34 (2006) 232-234
16. Lo Y.L., Chan L.L., Pan A., and Ratnagopal P. Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi. J. Neurol. Neurosurg. Psychiatry 75 (2004) 436-440
17. Lo Y.L., Leoh T.H., Dan Y.F., Lim L.L., Seah A., Fook-Chong S., and Ratnagopal P. Presynaptic neuromuscular transmission defect in the Miller Fisher syndrome. Neurology 66 (2006) 148-149
18. Nemoto Y., Kuwabara S., Misawa S., Kawaguchi N., Hattori T., Takamori M., and Vincent A. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 76 (2005) 714-718
19. Odaka M., Yuki N., Yamada M., Koga M., Takemi T., Hirata K., and Kuwabara S. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 126 (2003) 2279-2290
20. Ogawara K., Kuwabara S., Mori M., Hattori T., Koga M., and Yuki N. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann. Neurol. 48 (2000) 624-631
21. O'Hanlon G.M., Plomp J.J., Chakrabarti M., Morrison I., Wagner E.R., Goodyear C.S., Yin X., Trapp B.D., Conner J., Molenaar P.C., Stewart S., Rowan E.G., and Willison H.J. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 124 (2001) 893-906
22. Plomp J.J., Molenaar P.C., O'Hanlon G.M., Jacobs B.C., Veitch J., Daha M.R., van Doorn P.A., van der Meche F.G., Vincent A., Morgan B.P., and Willison H.J. Miller Fisher anti-GQ1b antibodies: α-latrotoxin-like effects on motor end plates. Ann. Neurol. 45 (1999) 189-199
23. Roberts M., Willison H., Vincent A., and Newsom-Davis J. Serum factor in Miller-Fisher[sic] variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 343 (1994) 454-455
24. Saunders D.B. Clinical impact of single-fiber electromyography. Muscle Nerve Suppl. 11 (2002) S15-S20
25. Sartucci F., Cafforio G., Borghetti D., Domenici L., Orlandi G., and Murri L. Electrophysiological evidence by single fibre electromyography of neuromuscular transmission impairment in a case of Miller Fisher syndrome. Neurol. Sci. 26 (2005) 125-128
26. Spaans F., Vredeveld J.-W., Morré H.H.E., Jacobs B.C., and de Baet M.H. Dysfunction at the motor end-plate and axon membrane in Guillain-Barré syndrome: a single-fiber EMG study. Muscle Nerve 27 (2003) 426-434
27. Susuki K., Yuki N., and Hirata K. Fine specificity of anti-GQ1b IgG and clinical features. J. Neurol. Sci. 185 (2001) 5-9
28. Trontelj J.V., and Stålberg E. Jitter measurement by axonal micro-stimulation. guideline and technical notes. Electroencephalogr. Clin. Neurophysiol. 85 (1992) 30-37
29. Uncini A., and Lugaresi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve 22 (1999) 640-644
30. Willison H.J., and Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125 (2002) 2591-2625
31. Wirguin I., Ifergane G., Almog Y., Lieberman D., Bersudsky M., and Herishanu Y.O. Presynaptic neuromuscular transmission block in Guillain-Barré syndrome associated with anti-GQ1b antibodies. Neuromuscul. Dis. 12 (2002) 292-293
32. Yuki N., Susuki K., and Hirata K. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology 54 (2000) 1851-1853